Possible adjuvant cancer therapy by two prebiotics - Inulin or oligofructose

In Vivo

Volumn 19, Issue 1, 2005, Pages 201-204

  Taper, Henryk S ^a   Roberfroid, Marcel B ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Inulin; Oligofructose; Prebiotics

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FLUOROURACIL; FRUCTOSE; INULIN; METHOTREXATE; METHYLNITROSOUREA; PREBIOTIC AGENT; RAFTILINE; RAFTILOSE; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CANCER TRANSPLANTATION; CLINICAL PROTOCOL; CONTROLLED STUDY; DIET THERAPY; DRUG POTENTIATION; EXPERIMENTAL ANIMAL; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; RAT; RISK REDUCTION;

EID: 16244394837     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Milner JA: Reducing the risk of cancer. In: Functional Foods, pp.. 39-70 (Goldberg I, editor), New York: Chapman & Hall, 1994.
2. Roberfroid MB: Dietary modulation of experimental neoplastic development: role of fat and fiber content and caloric intake. Mutation Res 259: 351-362, 1991.
3. Williams CM and Dickerson JW: Nutrition and cancer. Some biochemical mechanism. Nutrition Res Rev 3: 45-100, 1991.
4. Roberfroid MB: A functional food: chicory fructo-oligosaccharides, a colonic food with prebiotic activity. World Ingred 3: 42-44, 1995.
5. Nossal CJV: Life, death and the immune system. Sci Amer 269: 1-30, 1993.
6. Perdigon G, Medici M, Bibas Bonet de Jorrat ME, Valverde de Budeguer M and Pesce de Ruiz Holgado A: Immunomodulating effects of lactic-acid bacteria on mucosal and tumoral immunity. Int J Immunother 9: 29-52, 1993.
7. Wattenberg L: Inhibition of carcinogenicity by minor dietary constituents. Cancer Res 52: 2085s-2091s, 1992.
8. Fuller R: Pro-biotics: The Scientific Basis. Chapman and Hall, London 1992.
9. Reddy GV, Shabani KM and Benerjee MR: Inhibitory effect of yogurt on Ehrlich ascites tumor cell proliferation. J Nat Cancer Inst 50: 815-817, 1973.
10. Reddy BS and Rivenson A: Inhibitory effect of Bifidobacterium longum on colon, mammary and liver carcinogenesis induced by 2-amino-3-methylimidazo-[4,5-f]-quinoline, a food mutagen. Cancer Res 53: 3914-3918, 1993.
11. Kato L, Kobayashi T, Yokokura T and Mutai M: Anti-tumor activity of Lactobacillus casei in mice. Gann 72: 517-523, 1981.
12. Koo M and Rao V: Long-term effect of Bifidobacteria and neosugar on precursor lesions of colonic cancer in CFI mice. Nutr Cancer 5: 137-147, 1991.
13. Tsuyuki S, Yamazaki S, Akashiba H, Kamimura H, Sekine K, Toida T, Saito M, Kawashima T and Ueda K: Tumor-suppressive effect of a cell wal preparation, WPG, from Bifidobacterium infantis in germ free and flora bearing mice Bifidobacteria Microflora 10: 43-52, 1991.
14. Gibson GR, Beatty EB, Wang X and Cummings JH: Selective stimulation of Bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108: 975-982, 1995.
15. Gibson GR and Roberfroid MB: Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125 1401-1412, 1995.
16. Fiordaliso MF, Kok N; Goethals F, Desaeger JP, Deboyser D, Roberfroid M and Delzenne N: Dietary oligofructose lowers triglycerides, phospholipids and cholesterol in serum and very low density lipoproteins of rats. Lipids 30: 163-167, 1995.
17. Kok N, Roberfroid M and Delzenne N: Involvement of lipogenesis in the lower VLDL secretion induced by oligofructose in rats. Br J Nutr 76: 881-890, 1996.
18. Roberfroid M: Dietary fiber, inulin and oligofructose: a review comparing their physiological effects. CRC Crit Rev Food Sci Tech 33: 103-148, 1993.
19. Van Loo J, Coussement P, De Leenheer L, Hoebregs H and Smits G: On the presence of inulin and oligofructose as natural ingredients in the western diet. CRS Crit Rev Food Sci Nutr 35: 525-552, 1991.
20. Taper HS, Wooley GW, Teller MN and Lardis MP: A new transplantable mouse liver tumor of spontaneous origin. Cancer Res 26 143-148, 1966.
21. Cappucino JG, Brown GF, Mountain SM, Spencer S and Tarnowski GS: Chemotherapeutic studies on a new transplantable mouse liver tumor (Taper liver tumor). Cancer Res 26: 689-694, 1966.
22. Taper HS and Roberfroid M: Influence of inulin and oligofructose on breast cancer tumor growth. J Nutr 129(Suppl. 7): 1488S-1491S, 1999.
23. Taper HS, Delzenne NM and Roberfroid MB: Growth inhibition of transplantable mouse tumors by non-digestible carbohydrates. Int J Cancer 71: 1109-1112, 1997.
24. Taper HS, Lemort C and Roberfroid MB: Inhibition effects of dietary inulin and oligofructose on the growth of transplantable mouse tumor. Anticancer Res 18: 4123-4126, 1998.
25. Taper HS and Roberfroid MB: Inhibitory effect of dietary inulin or oligofructose on the development of cancer metastases. Anticancer Res 20: 4291-4294, 2000.
26. Taper HS and Roberfroid MB: Non-toxic potentiation of cancer chemotherapy by dietary oligofructose or inulin. Nutr Cancer 38: 1-5, 2000.
27. Taper HS and Roberfroid MB: Inulin/oligofructose and anticancer therapy. Br J Nutr 87(Suppl 2): S283-S286, 2000.
28. Taper HS and Roberfroid MB: Non-toxic potentiation of cancer radiotherapy by dietary oligofructose or inulin. Anticancer Res 22: 3319-3324, 2002.
29. Wang X and Gibson G: Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J Apl Bact 75: 373-380, 1993.
30. Sekine K, Watanabe-Sekine E, Ohta J, Toida T, Tatsuki T, Kawashima T and Hashimoto Y: Induction of tumoricidal cells in vivo and in vitro by bacterial cell wall of Bifidobacterum infantis Bifidobacteria Microflora 13: 65-67, 1994.
31. Reddy BS, Hamid R and Rao CV: Effects of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis 18: 1371-1374, 1997.
32. Rowland JR, Rummey CJ, Coutts JT and Lievense LC: Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 18: 1371-1374, 1998.
33. Cay O, Radnell M. Jeppsson B, Ahren B and Bengmark S: Inhibitory effect of 2-deoxy-D-glucose on liver tumor growth in rats. J Cancer Res 52: 5794-5796, 1992.
34. Yamashita K, Kawai K and Itakura M: Effects of fructo-oligosaccharides on blood glucose and serum lipids in diabetic subjects. Nutr Res 4: 961-966, 1994.
35. Kuhajda FP, Jenner K, Wood FD, Hennigar RA, Jacobs LB, Dick JD and Pasternack GR: Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Nat Acad Sci USA 91: 6379-6383, 1994.